GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (LSE:BODI) » Definitions » Additional Paid-In Capital

Bodisen Biotech (LSE:BODI) Additional Paid-In Capital : £22.80 Mil(As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Additional Paid-In Capital?


Bodisen Biotech's quarterly additional paid-in capital declined from Sep. 2012 (£21.92 Mil) to Dec. 2012 (£21.88 Mil) but then increased from Dec. 2012 (£21.88 Mil) to Jun. 2013 (£22.80 Mil).

Bodisen Biotech's annual additional paid-in capital increased from Dec. 2010 (£22.66 Mil) to Dec. 2011 (£22.69 Mil) but then declined from Dec. 2011 (£22.69 Mil) to Dec. 2012 (£21.88 Mil).


Bodisen Biotech Additional Paid-In Capital Historical Data

The historical data trend for Bodisen Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Additional Paid-In Capital Chart

Bodisen Biotech Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.85 20.91 22.66 22.69 21.88

Bodisen Biotech Quarterly Data
Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Jun13
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.34 22.73 21.92 21.88 22.80

Bodisen Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Bodisen Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Bodisen Biotech (LSE:BODI) Business Description

Traded in Other Exchanges
N/A
Address
Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.